Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026)
Bicara Therapeutics' (BCAX) quarterly Tax Provisions came in at $52000.0 in Q1 2026, down 27.78% year-on-year from $72000.0 in Q1 2025, and down 1.89% quarter-over-quarter from $53000.0 in Q4 2025.
Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $52000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 27.78% year-over-year to $52000.0 in Q1 2026; TTM through Mar 2026 was $197000.0, a 23.64% decrease from a year earlier, with the FY2025 full-year figure at $217000.0, up 16.04% from the prior year.
- Tax Provisions declined to $52000.0 in Q1 2026 per BCAX's latest filing, from $53000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $186000.0 in Q4 2024 and bottomed at $1000.0 in Q1 2024.
- The 4-year median for Tax Provisions is $52000.0 (2025), against an average of $57625.0.
- Biggest YoY gain for Tax Provisions was 7100.0% in 2025; the steepest drop was 71.51% in 2025.
- Year by year, Tax Provisions stood at $5000.0 in 2023, then surged by 3620.0% to $186000.0 in 2024, then slumped by 71.51% to $53000.0 in 2025, then dropped by 1.89% to $52000.0 in 2026.
- Per Business Quant, the three latest BCAX Tax Provisions figures stand at $52000.0 (Q1 2026), $53000.0 (Q4 2025), and $40000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Bicara Therapeutics | 1.64 Bn | 1.64 Bn | - | 52,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 5,000.00 |